• OPEN AN ACCOUNT
Indian Indices
Nifty
26,202.95 -12.60
(-0.05%)
Sensex
85,706.67 -13.71
( -0.02%)
Bank Nifty
59,752.70 15.40
( 0.03%)
Nifty IT
37,405.50 -40.80
( -0.11%)
Global Indices
Nasdaq
47,737.43 289.30
(0.61%)
Dow Jones
6,869.48 35.87
(0.52%)
Hang Seng
50,220.95 53.85
(0.11%)
Nikkei 225
9,721.02 27.09
(0.28%)
Forex
USD-INR
89.30 0.10
(0.11%)
EUR-INR
103.54 0.22
(0.21%)
GBP-INR
118.23 0.49
(0.41%)
JPY-INR
0.57 0.00
(0.17%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
377.5672424
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
19.45
105007.87
EPS(TTM)
Face Value()
Div & Yield %
64.68
1
0.64
 

network 18 media & investments ltd
Maharashtra Seamless slides after Q2 PAT dips 43% YoY to Rs 125 crore; revenue down 11%
Nov 06,2025
On a consolidated basis, the company’s net profit dropped 43.1% year-on-year to Rs 125.23 crore, while total revenue declined 10.7% to Rs 1,234.43 crore in Q2 FY26 over Q2 FY25. Profit before tax stood at Rs 169.14 crore, down 42% from the year-ago period.

Total expenses decreased 2.3% YoY to Rs 1,061.62 crore. Employee benefits expense rose 9% to Rs 33.31 crore, while other expenses were lower by 7% at Rs 219.31 crore, indicating cost control efforts.

Maharashtra Seamless manufactures carbon and alloy steel seamless pipes, ERW steel pipes, and casting pipes. The company also operates a windmill.